1. Home
  2. SKX vs RGEN Comparison

SKX vs RGEN Comparison

Compare SKX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKX
  • RGEN
  • Stock Information
  • Founded
  • SKX 1992
  • RGEN 1981
  • Country
  • SKX United States
  • RGEN United States
  • Employees
  • SKX N/A
  • RGEN N/A
  • Industry
  • SKX Shoe Manufacturing
  • RGEN Medical/Dental Instruments
  • Sector
  • SKX Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • SKX Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • SKX 6.9B
  • RGEN 8.0B
  • IPO Year
  • SKX 1999
  • RGEN N/A
  • Fundamental
  • Price
  • SKX $62.09
  • RGEN $126.50
  • Analyst Decision
  • SKX Buy
  • RGEN Buy
  • Analyst Count
  • SKX 13
  • RGEN 12
  • Target Price
  • SKX $70.33
  • RGEN $172.67
  • AVG Volume (30 Days)
  • SKX 11.7M
  • RGEN 815.5K
  • Earning Date
  • SKX 04-24-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • SKX N/A
  • RGEN N/A
  • EPS Growth
  • SKX 9.64
  • RGEN N/A
  • EPS
  • SKX 4.16
  • RGEN N/A
  • Revenue
  • SKX $9,129,335,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • SKX $7.83
  • RGEN $13.93
  • Revenue Next Year
  • SKX $6.94
  • RGEN $14.35
  • P/E Ratio
  • SKX $14.91
  • RGEN N/A
  • Revenue Growth
  • SKX 10.66
  • RGEN 4.88
  • 52 Week Low
  • SKX $44.50
  • RGEN $102.97
  • 52 Week High
  • SKX $78.85
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • SKX 68.72
  • RGEN 44.61
  • Support Level
  • SKX $61.97
  • RGEN $123.10
  • Resistance Level
  • SKX $61.70
  • RGEN $135.47
  • Average True Range (ATR)
  • SKX 0.61
  • RGEN 6.98
  • MACD
  • SKX 1.04
  • RGEN -0.97
  • Stochastic Oscillator
  • SKX 97.40
  • RGEN 25.20

About SKX Skechers U.S.A. Inc.

Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments includes Wholesale and Direct-to-Consumer. It generates maximum revenue from the Wholesale segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: